| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/15/1997 | CN1140053A Cosmetic for skin |
| 01/15/1997 | CN1033810C Process for enzymatic preparation of basic fibroblast growth factor |
| 01/15/1997 | CN1033809C Novel a-nor-steroid-3-carboxylic acid derivs. preparation method |
| 01/14/1997 | US5594144 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
| 01/14/1997 | US5594139 From 5-hal-2,6-diamino-3h-4-oxopyrimidine |
| 01/14/1997 | US5594024 Centrally actig substituted phenylazacycloalkanes |
| 01/14/1997 | US5594023 1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present |
| 01/14/1997 | US5594022 Carbamates |
| 01/14/1997 | US5594019 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles |
| 01/14/1997 | US5594014 Indole derivatives as 5-HT1 agonists |
| 01/14/1997 | US5594008 Pyrrolidine derivatives inhibitors of leukotriene biosynthesis |
| 01/14/1997 | US5593994 Prostaglandin synthase inhibitors |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593991 Imidazole compounds, use and process of making |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593981 Method and treatment of androgen-related diseases |
| 01/14/1997 | US5593980 Antiarthritic agents for administering |
| 01/14/1997 | US5593976 New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 01/14/1997 | US5593962 Treating calcium deficiency |
| 01/14/1997 | US5593884 Oncoprotein protein kinase |
| 01/14/1997 | US5593685 Ranitidine compositions |
| 01/14/1997 | US5593671 Method of attenuating lung capillary leak in a mammal |
| 01/14/1997 | US5593664 Polyamides, polyureas |
| 01/14/1997 | CA2070366C Prophylactic/therapeutic composition for swine pleuropneumonia |
| 01/14/1997 | CA1338845C Thiophene 2-carboxamide derivatives and their use as pharmaceuticals |
| 01/14/1997 | CA1338844C Thiophene carboxamine derivatives and their use as pharmaceuticals |
| 01/13/1997 | CA2181022A1 Cell-specific gene therapy using a novel promoter for tissue inhibitor of metalloproteinase-3 |
| 01/09/1997 | WO1997000892A2 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/09/1997 | WO1997000876A1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 01/09/1997 | WO1997000863A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/09/1997 | WO1997000860A1 Cb2 receptor agonist compounds |
| 01/09/1997 | WO1997000693A1 Novel formulation for peptide release |
| 01/09/1997 | WO1997000691A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | WO1997000675A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 01/09/1997 | WO1996040040A3 Thrombin receptor homolog |
| 01/09/1997 | WO1996039511A3 A c5a-like seven transmembrane receptor |
| 01/09/1997 | WO1996039050A3 Therapeutic system for dietary health management |
| 01/09/1997 | WO1996037214A3 Compositions of interleukin and pyrimidine nucleosides |
| 01/09/1997 | DE19626616A1 Verfahren zur Herstellung von 1,1-Dioxo-cephem-4-ketonen A process for the preparation of 1,1-dioxo-cephem-4-ketones |
| 01/09/1997 | DE19525924A1 Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel Cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them |
| 01/09/1997 | CA2225401A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | CA2225379A1 Cb2 receptor agonist compounds |
| 01/09/1997 | CA2225277A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 01/09/1997 | CA2224691A1 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/09/1997 | CA2220925A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/08/1997 | EP0752421A1 Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists |
| 01/08/1997 | EP0752249A2 Use of an angiotensin II antagonist and a benzofurane derivative having antiarithmic activity for the manufacture of a medicament for the treatment of cardiovascular disorders |
| 01/08/1997 | EP0752246A2 Kappa opiate agonists for inflammatory gut diseases |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
| 01/08/1997 | EP0751962A1 Methods and compositions for inhibiting cd14 mediated cell activation |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751948A1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 01/08/1997 | EP0751947A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
| 01/08/1997 | EP0751939A1 Naphthylamides as central nervous system agents |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |
| 01/08/1997 | EP0751778A1 Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same |
| 01/08/1997 | EP0751777A1 USE OF GINSENOSIDE R o? OR A PLANT EXTRACT CONTAINING SAME TO PROMOTE COLLAGEN SYNTHESIS |
| 01/08/1997 | EP0751776A1 Novel pharmaceutical composition for skin diseases |
| 01/08/1997 | EP0751773A1 Tocolytic oxytocin receptor antagonists |
| 01/08/1997 | EP0751770A1 8-substituted tetrahydro-beta-carbolines |
| 01/08/1997 | EP0751767A1 Therapeutic guanidines |
| 01/08/1997 | EP0751765A1 Sulfonamide derivatives and their use |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | EP0668863B1 Quinuclidine derivative as substance p antagonist |
| 01/08/1997 | EP0568577B1 Orally administerable drugs for the treatment of central dopamine deficiency conditions |
| 01/08/1997 | EP0538394B1 Treatment of male infertility |
| 01/08/1997 | EP0497828B1 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 01/08/1997 | EP0473724B1 A human cytokine, interleukin-9 |
| 01/08/1997 | EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/08/1997 | CN1139931A Cyclic neurokinin a antagonists |
| 01/08/1997 | CN1139929A Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
| 01/08/1997 | CN1139927A Substituted morpholine derivatives and their use as therapeutic agents |
| 01/08/1997 | CN1139917A Calcium receptor-active arylalkyl amines |
| 01/08/1997 | CN1139880A Diphenyl-2-propenoates and homologs thereof useful for threating diseases associated with leukotriene B4 |
| 01/08/1997 | CN1033759C 猪生长激素类似物 Porcine growth hormone analog |
| 01/08/1997 | CN1033752C (1H-A201-1Ylmethyl) ubstituted quinoline, quinazoline or quinoxaline derivatives |
| 01/07/1997 | US5591891 N-[Mercaptoacyl (amino acid or peptide ) ] compounds and S-lipophiIic aliphatic carbonyl derivatives thereof as antihypertensives |
| 01/07/1997 | US5591777 Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions |
| 01/07/1997 | US5591776 Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
| 01/07/1997 | US5591772 Dietary supplements |
| 01/07/1997 | US5591761 Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/07/1997 | US5591755 Pyridinyl thiadiazolyl compounds for treating glaucoma |
| 01/07/1997 | US5591753 Combination treatment for osteoporosis |
| 01/07/1997 | US5591749 Imidazopyridines as serotonergic 5-HT3 -antagonists |
| 01/07/1997 | US5591742 Treatment of angina, hypertension, atherosclerosis, cardiovascular disorders |
| 01/07/1997 | US5591740 Use of debromohymenialdisine for treating osteoarthritis |
| 01/07/1997 | US5591731 Crystalline amifostine compositions |
| 01/07/1997 | US5591711 Lysine-glycine-histidine tripeptide, fibroblast proliferation |
| 01/07/1997 | CA2038097C Method and composition for coiontophoresis |
| 01/07/1997 | CA2004606C Process for preparing optically active 2-oxoimidazolidine derivatives |
| 01/03/1997 | WO1997000268A1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
| 01/03/1997 | WO1997000261A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 01/03/1997 | WO1997000249A1 Heterocyclic compounds, their production and use |
| 01/03/1997 | WO1997000243A1 5-aminoalkyl-2-(2-alkoxyphenyl)-pyrrole derivatives having affinity for dopamine d3 receptors and their use in the treatment of psychoses |
| 01/03/1997 | WO1997000242A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 01/03/1997 | WO1997000074A1 USE OF IMIDAZO[1,5-a]QUINOLONES AS NEUROPROTECTIVE AGENTS |
| 01/03/1997 | WO1997000073A1 Novel use for pyrrole derivatives |
| 01/03/1997 | WO1997000069A1 Melatonin agonists for treating benign prostatic hyperplasia |
| 01/03/1997 | WO1997000063A2 Urocortin peptides |